Comprehensive analysis of splicing factor SRs-related gene characteristics: predicting osteosarcoma prognosis and immune regulation status
Changhai Long,
No information about this author
Biao Ma,
No information about this author
Kai Li
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: Sept. 2, 2024
Objective
To
investigate
the
impact
of
SRs-related
genes
on
overall
survival
and
prognosis
osteosarcoma
patients
through
bulk
single-cell
RNA-seq
transcriptome
analysis.
Methods
In
this
study,
we
constructed
a
model
based
serine/arginine-rich
splicing
factors
(SRs)
predicted
patients.
By
analyzing
RNA
sequencing
data
applying
AUCell
enrichment
analysis,
revealed
oncogenic
pathways
SRs
in
immune
cells.
Additionally,
described
regulatory
role
SRSF7
pan-cancer.
Results
Lasso
regression
analysis
identified
6
key
genes,
prediction
was
established.
The
upregulation
these
that
promote
tumor
cell
proliferation
by
regulating
related
signaling
help
cells
evade
host
surveillance.
grouping
using
AUCell,
found
significant
differences
T
expression
between
high
low-risk
groups.
results
indicated
activity
is
closely
to
function,
particularly
responses
promoting
evasion.
Furthermore,
regulates
apoptosis.
Conclusion
play
critical
osteosarcoma.
are
evasion
genes.
gene
influencing
occurrence
development
Language: Английский
YB1 and its role in osteosarcoma: a review
Fan Wu,
No information about this author
Dapeng Li
No information about this author
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: Oct. 21, 2024
YB1
(Y
box
binding
protein
1),
a
multifunctional
capable
of
to
DNA/RNA,
is
present
in
most
cells
and
acts
as
splicing
factor.
It
involved
numerous
cellular
processes
such
transcription,
translation,
DNA
repair,
significantly
affecting
cell
proliferation,
differentiation,
apoptosis.
Abnormal
expression
this
closely
linked
the
formation
various
malignancies
(osteosarcoma,
nasopharyngeal
carcinoma,
breast
cancer,
etc.).
This
review
examines
multifaceted
functions
its
critical
role
osteosarcoma
progression,
providing
new
perspectives
for
potential
therapeutic
strategies.
Language: Английский
Alternative splicing modulates chromatin interactome and phase separation of the RIF1 C-terminal domain
Adenine Si-Hui Koo,
No information about this author
Weiyan Jia,
No information about this author
Sang Hwa Kim
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
ABSTRACT
RIF1
(RAP1
interacting
factor)
fulfills
diverse
roles
in
DNA
double-strand
break
repair,
replication,
and
nuclear
organization.
is
expressed
as
two
splice
variants,
RIF1-Long
(RIF1-L)
RIF1-Short
(RIF1-S),
from
the
alternative
splicing
(AS)
of
Exon
32
(Ex32)
which
encodes
a
26
aa
Ser/Lys-rich
cassette
peptide
C-terminal
domain
(CTD).
Here
we
demonstrate
that
Ex32
inclusion
was
repressed
by
damage
oncogenesis
but
peaked
at
G
2
/M
phase
cell
cycle.
splice-in
catalyzed
positive
regulators
including
SRSF1,
bound
to
directly,
negative
such
PTBP1
SRSF3.
Isoform
proteomics
revealed
enhanced
association
RIF1-L
with
MDC1,
whose
recruitment
IR-induced
foci
strengthened
RIF1-L.
RIF1-S
also
exhibited
unique
separation
chromatin-binding
characteristics
were
regulated
CDK1-dependent
CTD
phosphorylation.
These
combined
findings
suggest
AS
affects
multiple
aspects
function
genome
protection
Graphical
Abstract
HIGHLIGHTS
dynamically
cycle
signaling.
isoform
switch
associated
primary
cancers.
SRSF1
acts
directly
on
promote
expression.
S/K
expanded
chromatin
interactomes
stabilized
separation.
Language: Английский